Knaus HA et al. found that AML blasts can directly modulate the viability, expansion, cosignal transduction, and senescence marker expression of CD8+ T cells in vitro and that the dysfunction of T cells is associated with the treatment response [8]. The gene discussed is CD8A; the disease is acute myeloid leukemia.